Age-specific anti-Müllerian hormone and electrocardiographic silent coronary artery disease

References

• Nowbar AN, Howard JP, Finegold JA, Asaria P, Francis DP. 2014 global geographic analysis of mortality from ischaemic heart disease by country, age and income: statistics from World Health Organisation and United Nations. Int J Cardiol 2014;174:293–8
   PubMed Web of Science ®Google Scholar
• Goff DC Jr, Lloyd-Jones DM, Bennett G, et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2014;129(Suppl 2):S49–S73
   Google Scholar
• Vitale C, Miceli M, Rosano GM. Gender-specific characteristics of atherosclerosis in menopausal women: risk factors, clinical course and strategies for prevention. Climacteric 2007;10(Suppl 2):16–20
   PubMed Web of Science ®Google Scholar
• Moller-Leimkuhler AM. Gender differences in cardiovascular disease and comorbid depression. Dialogues Clin Neurosci 2007;9:71–83
   PubMedGoogle Scholar
• Lee LV, Foody JM. Cardiovascular disease in women. Curr Atheroscler Rep 2008;10:295–302
   PubMed Web of Science ®Google Scholar
• McKinlay SM, Bifano NL, McKinlay JB. Smoking and age at menopause in women. Ann Intern Med 1985;103:350–6
   PubMed Web of Science ®Google Scholar
• de Kat AC, Broekmans FJ, Laven JS, van der Schouw YT. Anti-Mullerian hormone as a marker of ovarian reserve in relation to cardio-metabolic health: a narrative review. Maturitas 2015;80:251–7
   PubMed Web of Science ®Google Scholar
• Karkanaki A, Vosnakis C, Panidis D. The clinical significance of anti-Mullerian hormone evaluation in gynecological endocrinology. Hormones (Athens) 2011;10:95–103
   PubMedGoogle Scholar
• de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC. Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 2002;77:357–62
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Shakeri N, Solaymani-Dodaran M, Azizi F. Predicting age at menopause from serum antimullerian hormone concentration. Menopause 2011;18:766–70
   PubMed Web of Science ®Google Scholar
• Bleil ME, Gregorich SE, McConnell D, Rosen MP, Cedars MI. Does accelerated reproductive aging underlie premenopausal risk for cardiovascular disease? Menopause 2013;20:1139–46
   PubMed Web of Science ®Google Scholar
• Anderson EL, Fraser A, McNally W, et al. Anti-mullerian hormone is not associated with cardiometabolic risk factors in adolescent females. PLoS One 2013;8:e64510
   PubMed Web of Science ®Google Scholar
• Magnani JW, Newton-Cheh C, O'Donnell CJ, Levy D. Development and application of a longitudinal electrocardiogram repository: the Framingham Heart Study. J Electrocardiol 2012;45:673–6
   PubMed Web of Science ®Google Scholar
• Horibe H, Kasagi F, Kagaya M, et al. A nineteen-year cohort study on the relationship of electrocardiographic findings to all cause mortality among subjects in the national survey on circulatory disorders, NIPPON DATA80. J Epidemiol 2005;15:125–34
   PubMed Web of Science ®Google Scholar
• Rautaharju PM, Ge S, Nelson JC, et al. Comparison of mortality risk for electrocardiographic abnormalities in men and women with and without coronary heart disease (from the Cardiovascular Health Study). Am J Cardiol 2006;97:309–15
   PubMed Web of Science ®Google Scholar
• Azizi F, Rahmani M, Emami H, et al. Cardiovascular risk factors in an Iranian urban population: Tehran Lipid and Glucose Study (phase 1). Soz Praventivmed 2002;47:408–26
   PubMedGoogle Scholar
• Prineas RJ, Crow RS, Blackburn HW. The Minnesota code manual of electrocardiographic findings: standards and procedures for measurement and classification. Boston, USAS: J. Wright, 1982
   Google Scholar
• Altman DG, Chitty LS. Charts of fetal size. 1. Methodology. Br J Obstet Gynaecol 1994;101:29–34
   PubMedGoogle Scholar
• Royston P, Wright EM. How to construct 'normal ranges' for fetal variables. Ultrasound Obstet Gynecol 1998;11:30–8
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Mansournia MA, Solaymani-Dodaran M, Azizi F. Age-specific serum anti-Mullerian hormone levels: estimates from a large population-based sample. Climacteric 2014;17:591–7
   PubMed Web of Science ®Google Scholar
• Khalili D, Asgari S, Hadaegh F, et al. A new approach to test validity and clinical usefulness of the 2013 ACC/AHA guideline on statin therapy: A population-based study. Int J Cardiol 2015;184:587–94
   PubMed Web of Science ®Google Scholar
• Rose G, McCartney P, Reid DD. Self-administration of a questionnaire on chest pain and intermittent claudication. Br J Prev Soc Med 1977;31:42–8
   PubMedGoogle Scholar
• Marmot MG, Smith GD, Stansfeld S, et al. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991;337:1387–93
   PubMed Web of Science ®Google Scholar
• Smith GD, Shipley MJ, Rose G. Intermittent claudication, heart disease risk factors, and mortality. The Whitehall Study. Circulation 1990;82:1925–31
   PubMed Web of Science ®Google Scholar
• OpenEpi. Available at: http://www.openepi.com/SampleSize/SSCohort.htm
   Google Scholar
• Zethelius B, Berglund L, Sundstrom J, et al. Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008;358:2107–16
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani F, Behboudi-Gandevani S, Ghasemi A, Azizi F. Association between serum concentrations of nitric oxide and transition to menopause. Acta Obstet Gynecol Scand 2015;94:708–14
   PubMed Web of Science ®Google Scholar
• Kuh D, Langenberg C, Hardy R, et al. Cardiovascular risk at age 53 years in relation to the menopause transition and use of hormone replacement therapy: a prospective British birth cohort study. BJOG 2005;112:476–85
   PubMed Web of Science ®Google Scholar
• Ramezani Tehrani F, Behboudi-Gandevani S, Ghanbarian A, Azizi F. Effect of menopause on cardiovascular disease and its risk factors: a 9-year follow-up study. Climacteric 2014;17:164–72
   PubMed Web of Science ®Google Scholar
• Ebong IA, Watson KE, Goff DC Jr, et al. Age at menopause and incident heart failure: the Multi-Ethnic Study of Atherosclerosis. Menopause 2014;21:585–91
   PubMed Web of Science ®Google Scholar
• Tehrani FR, Erfani H, Cheraghi L, Tohidi M, Azizi F. Lipid profiles and ovarian reserve status: a longitudinal study. Hum Reprod 2014;29:2522–9
   PubMed Web of Science ®Google Scholar
• Pinola P, Morin-Papunen LC, Bloigu A, et al. Anti-Mullerian hormone: correlation with testosterone and oligo- or amenorrhoea in female adolescence in a population-based cohort study. Hum Reprod 2014;29:2317–25
   PubMed Web of Science ®Google Scholar
• van Dorp W, Blijdorp K, Laven JS, et al. Decreased ovarian function is associated with obesity in very long-term female survivors of childhood cancer. Eur J Endocrinol 2013;168:905–12
   PubMed Web of Science ®Google Scholar
• Park HT, Cho GJ, Ahn KH, et al. Association of insulin resistance with anti-Mullerian hormone levels in women without polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf) 2010;72:26–31
   PubMed Web of Science ®Google Scholar